Aktiengesellschaft Bayer Wo... Net Worth

The estimated Net Worth of Aktiengesellschaft Bayer Wo... is at least $1.89 Miliarda dollars as of 3 December 2020. Aktiengesellschaft Wo owns over 54,500,000 units of Elanco Animal Health Inc stock worth over $267,104,292 and over the last 4 years Aktiengesellschaft sold ELAN stock worth over $1,626,280,000.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Aktiengesellschaft Wo ELAN stock SEC Form 4 insiders trading

Aktiengesellschaft has made over 1 trades of the Elanco Animal Health Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently Aktiengesellschaft sold 54,500,000 units of ELAN stock worth $1,626,280,000 on 3 December 2020.

The largest trade Aktiengesellschaft's ever made was selling 54,500,000 units of Elanco Animal Health Inc stock on 3 December 2020 worth over $1,626,280,000. On average, Aktiengesellschaft trades about 54,500,000 units every 0 days since 2020. As of 3 December 2020 Aktiengesellschaft still owns at least 18,446,429 units of Elanco Animal Health Inc stock.

You can see the complete history of Aktiengesellschaft Wo stock trades at the bottom of the page.

What's Aktiengesellschaft Wo's mailing address?

Aktiengesellschaft's mailing address filed with the SEC is KAISER-WILHELM-ALLEE 1ENERGIEWEG 1, , LEVERKUSENMIJDRECHT, 2MP7, D-523683641.

Insiders trading at Elanco Animal Health Inc

Over the last 6 years, insiders at Elanco Animal Health Inc have traded over $1,626,280,000 worth of Elanco Animal Health Inc stock and bought 657,104 units worth $14,225,149 . The most active insiders traders include Aktiengesellschaft Bayer Wo..., Scott D.Sachem Head Capital... a R David Hoover. On average, Elanco Animal Health Inc executives and independent directors trade stock every 38 days with the average trade being worth of $14,011,833. The most recent stock trade was executed by Michael J Harrington on 22 August 2024, trading 3,500 units of ELAN stock currently worth $51,975.

What does Elanco Animal Health Inc do?

elanco is a global animal health company. our vision: food and companionship enriching life. elanco fulfills this vision through three primary pursuits: - helping deliver a safe, more affordable, more abundant food supply by improving the health and performance of animals - helping pets live longer, healthier, higher-quality lives - improving food safety elanco employees are empowered to preserve elanco’s common culture of humility, discipline and involvement. we have a responsibility to connect and contribute to our cause, to be passionate about delivering solutions and value to our customers, and to embrace opportunities for personal and professional growth and development. through innovative products, quality systems and a shared vision, elanco strives daily to enhance animal health—and enrich the lives of people worldwide.

Complete history of Aktiengesellschaft Wo stock trades at Elanco Animal Health Inc

Elanco Animal Health Inc executives and stock owners

Elanco Animal Health Inc executives and other stock owners filed with the SEC include:

• Jeffrey Simmons,
  President, Chief Executive Officer, Director
• Sarena Lin,
  Executive Vice President, Global Marketing, Corporate Strategy and Transformation
• David Kinard,
  Executive Vice President of Human Resources
• David Urbanek,
  Executive Vice President - Manufacturing, Quality
• Aaron Schacht,
  Executive Vice President - Innovation, Regulatory, Business Development
• Todd Young,
  Chief Financial Officer, Executive Vice President
• Jeffrey N. Simmons,
  Pres, CEO & Director
• Todd S. Young,
  Exec. VP of Corp. Governance and Strategy & CFO
• R. David Hoover,
  Independent Chairman of the Board
• Kapila Anand,
  Independent Director
• Lawrence Kurzius,
  Independent Director
• Michael Harrington,
  Independent Director
• John Bilbrey,
  Independent Director
• Denise Scots-Knight,
  Independent Director
• Kirk McDonald,
  Independent Director
• Deborah Kochevar,
  Independent Director
• Art Garcia,
  Independent Director
• Joshua Smiley,
  Independent Director
• Aarti Shah,
  Independent Director
• David Ricks,
  Independent Director
• Carl McMillian,
  Independent Director
• James Meer,
  Chief Accounting Officer, Vice President
• Ramiro Cabral,
  Executive Vice President - Elanco International
• Michael-Bryant Hicks,
  Executive Vice President, General Counsel, Corporate Secretary
• Larbi Van Lier,
  Sr. VP of Asia
• Shawn McKee,
  Sr. VP of U.S. Companion Animal
• David Alan Urbanek,
  Exec. VP of Manufacturing & Quality
• Ramiro Martin Cabral,
  Exec. VP of Elanco International
• Racquel Harris Mason,
  Exec. VP & Chief Marketing Officer
• Marcela A. Kirberger,
  Exec. VP, Gen. Counsel & Corp. Sec.
• Tiffany Ann Kanaga,
  Head of Investor Relations
• David S. Kinard,
  Exec. VP of HR Corp. Affairs & Admin.
• Chris Keeley,
  Sr. VP & Chief Information Officer
• James M. Meer,
  VP & Chief Accounting Officer
• De Simas Jose Manuel Correia,
  SEE REMARKS
• Lilly & Co Eli,
  10% owner
• Timothy J Bettington,
  SEE REMARKS
• Aktiengesellschaft Bayer Wo...,
  
• Racquel Harris Mason,
  See Remarks
• Dirk Ehle,
  Ex VP & Pres Elanco Europe
• Joyce J. Lee,
  Ex VP Prs US Pet Hlth Com Op
• Rajeev A. Modi,
  SEE REMARKS
• Paul Herendeen,
  
• Marcela A. Kirberger,
  SEE REMARKS
• William F Doyle,
  
• Scott D.Sachem Head Capital...,
  
• Brabander Ellen De,
  SEE REMARKS
• Shiv O'neill,
  GC AND CORP SEC
• Grace Mc Ardle,
  EVP, MANUFACTURING AND QUALITY